# Regeneron Pharmaceuticals, Inc. (REGN) — Q4-2008 Earnings Results

**Report date:** 2009-02-26 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/REGN/earnings/Q4-2008

## Post-Earnings Brief

### Headline

Regeneron Pharmaceuticals Misses on EPS — Stock Down 10.72%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.40 | N/A | -34.68% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management's tone was defensive, reflecting the difficulties faced in the current market. They did not provide specific guidance for future quarters.

**Key quotes:**

> Management expressed concerns about current market conditions impacting performance.

> They highlighted ongoing challenges in the pharmaceutical landscape.

### Guidance Changes

No guidance data was provided during the earnings call.

### What It Means

Regeneron's earnings report indicates a challenging quarter, with the company missing EPS expectations. The stock reacted negatively, dropping 10.72%, likely due to investor concerns about the company's performance and lack of guidance. This could signal potential difficulties ahead as the company navigates a tough market environment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/REGN/earnings/Q4-2008_